Development of a supramolecular nanocarrier for gene delivery based on cationic block copolymers

Yuichi Yamasaki, Woo Dong Jang, Nobuhiro Nishiyama, Naoki Kanayama, Kazunori Kataoka

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

5 Conclusions: In this chapter, recent trends in the development of supramolecular nanocarriers of genes and related compounds, based on cationic copolymers, was highlighted. PEG is widely used as the non-ionic and hydrophilic parts of these non-viral gene carriers, as it has been approved by the FDA for use in pharmaceutical formulations. The PEGylation of proteins and peptide drugs has led to an improvement of their pharmacokinetics, proving the validity of using PEG to improve drug efficacy. Similarly, it is expected that PEGylation of gene carriers offers great promise for their optimization. Recent progress in the development of novel synthetic backbones for various kinds of PEG conjugates as well as preparation procedures for sophisticated polyplexes further extend the applicability of PEGylated gene carriers. PEG conjugates possessing moieties that are responsive to changes in their chemical and biological environment act as environmentally responsive polyplexes that can release therapeutic genes in response to external stimuli. Surface modification of polyplexes using ligands attached to the distal end of the PEG segment significantly enhances the internalization efficiency of polyplexes into the cytoplasm. In addition, various functional counterparts to the PEG segment are also available due to the recent development of regulated polymerization techniques. Currently, numerous studies are focusing on polyplex-based PEG-polycation copolymers with respect to their safety and gene transfection efficiency. Investigations of block- and graft-copolymer-based gene delivery systems have progressed rapidly, and is expected to lead to progress in engineered syntheses of PEG-based block and graft copolymers.

Original languageEnglish
Title of host publicationNon-viral Gene Therapy
Subtitle of host publicationGene Design and Delivery
PublisherSpringer-Verlag Tokyo
Pages51-62
Number of pages12
ISBN (Electronic)9784431278795
ISBN (Print)4431251227, 9784431251224
DOIs
Publication statusPublished - 2005 Jan 1

Fingerprint

Polyethylene glycols
Block copolymers
Genes
Graft copolymers
Transplants
Gene Transfer Techniques
Drug Compounding
Copolymers
Pharmaceutical Preparations
Polymerization
Pharmacokinetics
Transfection
Cytoplasm
Ligands
Surface treatment
Safety
Peptides
Proteins

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Yamasaki, Y., Jang, W. D., Nishiyama, N., Kanayama, N., & Kataoka, K. (2005). Development of a supramolecular nanocarrier for gene delivery based on cationic block copolymers. In Non-viral Gene Therapy: Gene Design and Delivery (pp. 51-62). Springer-Verlag Tokyo. https://doi.org/10.1007/4-431-27879-6_5
Yamasaki, Yuichi ; Jang, Woo Dong ; Nishiyama, Nobuhiro ; Kanayama, Naoki ; Kataoka, Kazunori. / Development of a supramolecular nanocarrier for gene delivery based on cationic block copolymers. Non-viral Gene Therapy: Gene Design and Delivery. Springer-Verlag Tokyo, 2005. pp. 51-62
@inbook{f467f61a27c54cea89c84f05f9126c26,
title = "Development of a supramolecular nanocarrier for gene delivery based on cationic block copolymers",
abstract = "5 Conclusions: In this chapter, recent trends in the development of supramolecular nanocarriers of genes and related compounds, based on cationic copolymers, was highlighted. PEG is widely used as the non-ionic and hydrophilic parts of these non-viral gene carriers, as it has been approved by the FDA for use in pharmaceutical formulations. The PEGylation of proteins and peptide drugs has led to an improvement of their pharmacokinetics, proving the validity of using PEG to improve drug efficacy. Similarly, it is expected that PEGylation of gene carriers offers great promise for their optimization. Recent progress in the development of novel synthetic backbones for various kinds of PEG conjugates as well as preparation procedures for sophisticated polyplexes further extend the applicability of PEGylated gene carriers. PEG conjugates possessing moieties that are responsive to changes in their chemical and biological environment act as environmentally responsive polyplexes that can release therapeutic genes in response to external stimuli. Surface modification of polyplexes using ligands attached to the distal end of the PEG segment significantly enhances the internalization efficiency of polyplexes into the cytoplasm. In addition, various functional counterparts to the PEG segment are also available due to the recent development of regulated polymerization techniques. Currently, numerous studies are focusing on polyplex-based PEG-polycation copolymers with respect to their safety and gene transfection efficiency. Investigations of block- and graft-copolymer-based gene delivery systems have progressed rapidly, and is expected to lead to progress in engineered syntheses of PEG-based block and graft copolymers.",
author = "Yuichi Yamasaki and Jang, {Woo Dong} and Nobuhiro Nishiyama and Naoki Kanayama and Kazunori Kataoka",
year = "2005",
month = "1",
day = "1",
doi = "10.1007/4-431-27879-6_5",
language = "English",
isbn = "4431251227",
pages = "51--62",
booktitle = "Non-viral Gene Therapy",
publisher = "Springer-Verlag Tokyo",

}

Yamasaki, Y, Jang, WD, Nishiyama, N, Kanayama, N & Kataoka, K 2005, Development of a supramolecular nanocarrier for gene delivery based on cationic block copolymers. in Non-viral Gene Therapy: Gene Design and Delivery. Springer-Verlag Tokyo, pp. 51-62. https://doi.org/10.1007/4-431-27879-6_5

Development of a supramolecular nanocarrier for gene delivery based on cationic block copolymers. / Yamasaki, Yuichi; Jang, Woo Dong; Nishiyama, Nobuhiro; Kanayama, Naoki; Kataoka, Kazunori.

Non-viral Gene Therapy: Gene Design and Delivery. Springer-Verlag Tokyo, 2005. p. 51-62.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Development of a supramolecular nanocarrier for gene delivery based on cationic block copolymers

AU - Yamasaki, Yuichi

AU - Jang, Woo Dong

AU - Nishiyama, Nobuhiro

AU - Kanayama, Naoki

AU - Kataoka, Kazunori

PY - 2005/1/1

Y1 - 2005/1/1

N2 - 5 Conclusions: In this chapter, recent trends in the development of supramolecular nanocarriers of genes and related compounds, based on cationic copolymers, was highlighted. PEG is widely used as the non-ionic and hydrophilic parts of these non-viral gene carriers, as it has been approved by the FDA for use in pharmaceutical formulations. The PEGylation of proteins and peptide drugs has led to an improvement of their pharmacokinetics, proving the validity of using PEG to improve drug efficacy. Similarly, it is expected that PEGylation of gene carriers offers great promise for their optimization. Recent progress in the development of novel synthetic backbones for various kinds of PEG conjugates as well as preparation procedures for sophisticated polyplexes further extend the applicability of PEGylated gene carriers. PEG conjugates possessing moieties that are responsive to changes in their chemical and biological environment act as environmentally responsive polyplexes that can release therapeutic genes in response to external stimuli. Surface modification of polyplexes using ligands attached to the distal end of the PEG segment significantly enhances the internalization efficiency of polyplexes into the cytoplasm. In addition, various functional counterparts to the PEG segment are also available due to the recent development of regulated polymerization techniques. Currently, numerous studies are focusing on polyplex-based PEG-polycation copolymers with respect to their safety and gene transfection efficiency. Investigations of block- and graft-copolymer-based gene delivery systems have progressed rapidly, and is expected to lead to progress in engineered syntheses of PEG-based block and graft copolymers.

AB - 5 Conclusions: In this chapter, recent trends in the development of supramolecular nanocarriers of genes and related compounds, based on cationic copolymers, was highlighted. PEG is widely used as the non-ionic and hydrophilic parts of these non-viral gene carriers, as it has been approved by the FDA for use in pharmaceutical formulations. The PEGylation of proteins and peptide drugs has led to an improvement of their pharmacokinetics, proving the validity of using PEG to improve drug efficacy. Similarly, it is expected that PEGylation of gene carriers offers great promise for their optimization. Recent progress in the development of novel synthetic backbones for various kinds of PEG conjugates as well as preparation procedures for sophisticated polyplexes further extend the applicability of PEGylated gene carriers. PEG conjugates possessing moieties that are responsive to changes in their chemical and biological environment act as environmentally responsive polyplexes that can release therapeutic genes in response to external stimuli. Surface modification of polyplexes using ligands attached to the distal end of the PEG segment significantly enhances the internalization efficiency of polyplexes into the cytoplasm. In addition, various functional counterparts to the PEG segment are also available due to the recent development of regulated polymerization techniques. Currently, numerous studies are focusing on polyplex-based PEG-polycation copolymers with respect to their safety and gene transfection efficiency. Investigations of block- and graft-copolymer-based gene delivery systems have progressed rapidly, and is expected to lead to progress in engineered syntheses of PEG-based block and graft copolymers.

UR - http://www.scopus.com/inward/record.url?scp=84920096502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920096502&partnerID=8YFLogxK

U2 - 10.1007/4-431-27879-6_5

DO - 10.1007/4-431-27879-6_5

M3 - Chapter

AN - SCOPUS:84920096502

SN - 4431251227

SN - 9784431251224

SP - 51

EP - 62

BT - Non-viral Gene Therapy

PB - Springer-Verlag Tokyo

ER -

Yamasaki Y, Jang WD, Nishiyama N, Kanayama N, Kataoka K. Development of a supramolecular nanocarrier for gene delivery based on cationic block copolymers. In Non-viral Gene Therapy: Gene Design and Delivery. Springer-Verlag Tokyo. 2005. p. 51-62 https://doi.org/10.1007/4-431-27879-6_5